+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1tfg | ||||||
---|---|---|---|---|---|---|---|
タイトル | AN UNUSUAL FEATURE REVEALED BY THE CRYSTAL STRUCTURE AT 2.2 ANGSTROMS RESOLUTION OF HUMAN TRANSFORMING GROWTH FACTOR-BETA2 | ||||||
![]() | TRANSFORMING GROWTH FACTOR, BETA 2 | ||||||
![]() | GROWTH FACTOR | ||||||
機能・相同性 | ![]() regulation of timing of catagen / regulation of apoptotic process involved in outflow tract morphogenesis / negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation / substantia propria of cornea development / ascending aorta morphogenesis / positive regulation of activation-induced cell death of T cells / cardioblast differentiation / uterine wall breakdown / positive regulation of timing of catagen / positive regulation of cardioblast differentiation ...regulation of timing of catagen / regulation of apoptotic process involved in outflow tract morphogenesis / negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation / substantia propria of cornea development / ascending aorta morphogenesis / positive regulation of activation-induced cell death of T cells / cardioblast differentiation / uterine wall breakdown / positive regulation of timing of catagen / positive regulation of cardioblast differentiation / cardiac right ventricle morphogenesis / regulation of transforming growth factor beta2 production / atrial septum morphogenesis / pharyngeal arch artery morphogenesis / positive regulation of heart contraction / type III transforming growth factor beta receptor binding / positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation / activation-induced cell death of T cells / glial cell migration / positive regulation of extracellular matrix disassembly / negative regulation of macrophage cytokine production / secondary palate development / somatic stem cell division / positive regulation of integrin biosynthetic process / atrial septum primum morphogenesis / endocardial cushion fusion / heart valve morphogenesis / TGFBR3 regulates TGF-beta signaling / membranous septum morphogenesis / negative regulation of cartilage development / cardiac epithelial to mesenchymal transition / signaling / positive regulation of stress-activated MAPK cascade / neuron fate commitment / pericyte cell differentiation / embryonic digestive tract development / transforming growth factor beta receptor binding / eye development / neural retina development / pulmonary valve morphogenesis / type II transforming growth factor beta receptor binding / cranial skeletal system development / ventricular trabecula myocardium morphogenesis / negative regulation of Ras protein signal transduction / embryo development ending in birth or egg hatching / outflow tract septum morphogenesis / positive regulation of extrinsic apoptotic signaling pathway in absence of ligand / cell-cell junction organization / collagen fibril organization / embryonic limb morphogenesis / positive regulation of cell adhesion mediated by integrin / atrioventricular valve morphogenesis / face morphogenesis / odontogenesis / endocardial cushion morphogenesis / Molecules associated with elastic fibres / dopamine biosynthetic process / hair follicle morphogenesis / cartilage condensation / generation of neurons / ventricular septum morphogenesis / positive regulation of Notch signaling pathway / uterus development / inner ear development / TGF-beta receptor signaling activates SMADs / hemopoiesis / positive regulation of cell division / positive regulation of SMAD protein signal transduction / positive regulation of epithelial cell migration / epithelial to mesenchymal transition / blood vessel remodeling / hair follicle development / cardiac muscle cell proliferation / ECM proteoglycans / neuron development / positive regulation of epithelial to mesenchymal transition / heart morphogenesis / salivary gland morphogenesis / extrinsic apoptotic signaling pathway / positive regulation of cell cycle / extrinsic apoptotic signaling pathway in absence of ligand / neutrophil chemotaxis / epithelial cell differentiation / transforming growth factor beta receptor signaling pathway / axon guidance / response to progesterone / negative regulation of angiogenesis / platelet alpha granule lumen / cytokine activity / skeletal system development / positive regulation of protein secretion / regulation of actin cytoskeleton organization / neural tube closure / growth factor activity / kidney development / wound healing / negative regulation of cell growth / positive regulation of immune response / positive regulation of miRNA transcription / response to wounding 類似検索 - 分子機能 | ||||||
生物種 | ![]() | ||||||
手法 | ![]() | ||||||
![]() | Gruetter, M. / Schlunegger, M. | ||||||
![]() | ![]() タイトル: An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2. 著者: Schlunegger, M.P. / Grutter, M.G. #1: ![]() タイトル: Crystallization and Preliminary X-Ray Analysis of Recombinant Human Transforming Growth Factor Beta2 著者: Schlunegger, M.P. / Cerletti, N. / Cox, D.A. / Mcmaster, G.K. / Schmitz, A. / Gruetter, M.G. #2: ![]() タイトル: Crystal Structure of Transforming Growth Factor-Beta2: An Unusual Fold for the Superfamily 著者: Daopin, S. / Piez, K.A. / Ogawa, Y. / Davies, D.R. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 35.7 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 23.9 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 361.7 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 360.8 KB | 表示 | |
XML形式データ | ![]() | 3.6 KB | 表示 | |
CIF形式データ | ![]() | 5.5 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||
単位格子 |
| ||||||||
Atom site foot note | 1: RESIDUE 36 IS A CIS PROLINE. |
-
要素
#1: タンパク質 | 分子量: 12732.597 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() |
---|---|
#2: 水 | ChemComp-HOH / |
Has protein modification | Y |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 3.13 Å3/Da / 溶媒含有率: 60.69 % | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | *PLUS pH: 3 / 手法: 蒸気拡散法, ハンギングドロップ法 | |||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
反射 | *PLUS 最高解像度: 1.8 Å / Num. obs: 14995 / Rmerge(I) obs: 0.106 |
---|
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 解像度: 1.95→8 Å / Rfactor Rwork: 0.194 / Rfactor obs: 0.194 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 1.95→8 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS 最高解像度: 1.95 Å / 最低解像度: 8 Å / Rfactor obs: 0.194 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 | *PLUS タイプ: x_angle_d / Dev ideal: 1.97 |